These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 27712593)
1. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway. Wang Y; Leng H; Chen H; Wang L; Jiang N; Huo X; Yu B Oncol Res; 2016; 24(5):361-369. PubMed ID: 27712593 [TBL] [Abstract][Full Text] [Related]
2. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma. Hao P; Kang B; Li Y; Hao W; Ma F Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226 [TBL] [Abstract][Full Text] [Related]
3. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway. Qiao L; Dong C; Ma B J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway. Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636 [TBL] [Abstract][Full Text] [Related]
5. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway. Li YJ; Dong BK; Fan M; Jiang WX Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427 [TBL] [Abstract][Full Text] [Related]
6. UBE2T regulates epithelial-mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer. Cui P; Li H; Wang C; Liu Y; Zhang M; Yin Y; Sun Z; Wang Y; Chen X J Ovarian Res; 2022 Sep; 15(1):103. PubMed ID: 36088429 [TBL] [Abstract][Full Text] [Related]
7. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway. Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480 [TBL] [Abstract][Full Text] [Related]
8. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma. Yu C; Zhang B; Li YL; Yu XR Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230 [TBL] [Abstract][Full Text] [Related]
9. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway. Hu W; Xiao L; Cao C; Hua S; Wu D Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of Shen L; Zhao K; Li H; Ning B; Wang W; Liu R; Zhang Y; Zhang A Epigenomics; 2019 Aug; 11(11):1283-1305. PubMed ID: 31355678 [No Abstract] [Full Text] [Related]
11. TGF-β is associated with poor prognosis and promotes osteosarcoma progression Ma K; Zhang C; Li W Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027 [TBL] [Abstract][Full Text] [Related]
12. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma. He R; Wu JX; Zhang Y; Che H; Yang L Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of Homeobox B7 Inhibits the Tumorigenesis and Progression of Osteosarcoma. Yang L; Xie F; Li S Oncol Res; 2017 Aug; 25(7):1089-1095. PubMed ID: 27983923 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway. Li B; Yang Y; Jiang S; Ni B; Chen K; Jiang L Int J Oncol; 2012 Nov; 41(5):1809-19. PubMed ID: 22948234 [TBL] [Abstract][Full Text] [Related]
15. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling. Zhang Y; Cheng H; Li W; Wu H; Yang Y Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. Liu ZB; Wang JA; Lv RQ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway. Zhu LB; Jiang J; Zhu XP; Wang TF; Chen XY; Luo QF; Shu Y; Liu ZL; Huang SH Int J Clin Exp Pathol; 2014; 7(7):3984-91. PubMed ID: 25120775 [TBL] [Abstract][Full Text] [Related]
18. P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway. Song R; Tian K; Wang W; Wang L Int J Surg; 2015 Aug; 20():80-7. PubMed ID: 25936826 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma. Zheng S; Qiao G; Min D; Zhang Z; Lin F; Yang Q; Feng T; Tang L; Sun Y; Zhao H; Li H; Yu W; Yang Y; Shen Z; Yao Y Cancer Lett; 2015 Apr; 359(1):36-46. PubMed ID: 25578779 [TBL] [Abstract][Full Text] [Related]
20. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer. Wen M; Kwon Y; Wang Y; Mao JH; Wei G Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]